CINECA IRIS Institutional Research Information System

DEAGLIO, Silvia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.980
EU - Europa 6.590
AS - Asia 4.341
SA - Sud America 384
AF - Africa 166
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.490
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.837
IT - Italia 2.211
CN - Cina 1.897
SG - Singapore 1.300
IE - Irlanda 726
DE - Germania 679
SE - Svezia 597
UA - Ucraina 501
KR - Corea 426
FR - Francia 416
FI - Finlandia 347
AT - Austria 333
BR - Brasile 333
GB - Regno Unito 240
VN - Vietnam 165
PL - Polonia 142
HK - Hong Kong 125
SN - Senegal 119
CA - Canada 114
IN - India 94
JP - Giappone 85
NL - Olanda 71
BE - Belgio 64
ID - Indonesia 62
ES - Italia 54
CZ - Repubblica Ceca 31
CH - Svizzera 30
IR - Iran 27
UZ - Uzbekistan 26
RU - Federazione Russa 24
TW - Taiwan 24
MX - Messico 23
BY - Bielorussia 22
AU - Australia 20
DK - Danimarca 20
PH - Filippine 19
EG - Egitto 16
TR - Turchia 15
GR - Grecia 14
CL - Cile 13
RO - Romania 13
CO - Colombia 12
AR - Argentina 10
MO - Macao, regione amministrativa speciale della Cina 10
NG - Nigeria 9
PK - Pakistan 9
TH - Thailandia 9
AE - Emirati Arabi Uniti 8
MA - Marocco 8
NO - Norvegia 8
ZA - Sudafrica 8
LT - Lituania 7
LU - Lussemburgo 7
SA - Arabia Saudita 7
BD - Bangladesh 5
HU - Ungheria 5
IL - Israele 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
SI - Slovenia 5
EC - Ecuador 4
EU - Europa 4
LK - Sri Lanka 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
EE - Estonia 3
IQ - Iraq 3
PE - Perù 3
VE - Venezuela 3
AM - Armenia 2
BG - Bulgaria 2
HR - Croazia 2
IS - Islanda 2
JM - Giamaica 2
LB - Libano 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
PY - Paraguay 2
TN - Tunisia 2
AZ - Azerbaigian 1
CR - Costa Rica 1
DZ - Algeria 1
GH - Ghana 1
GT - Guatemala 1
IM - Isola di Man 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LI - Liechtenstein 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SV - El Salvador 1
TJ - Tagikistan 1
Totale 20.490
Salva come PNG Salva come JPEG
Città #
Chandler 1.206
Beijing 929
Singapore 752
Dublin 722
Santa Clara 646
Torino 608
Houston 435
Ashburn 430
Fairfield 399
Turin 327
Ann Arbor 312
Vienna 305
Jacksonville 287
Nyköping 250
Wilmington 247
Villeurbanne 244
Medford 238
Princeton 236
Columbus 228
Woodbridge 192
Dearborn 185
Milan 162
Cambridge 159
Seattle 138
Dong Ket 131
Warsaw 124
Boston 108
Guangzhou 105
Redwood City 103
Hong Kong 92
Shanghai 92
Fremont 86
New York 77
Nuremberg 73
Nanjing 69
Pisa 68
Hefei 64
Jakarta 62
Hangzhou 59
Düsseldorf 56
Boardman 53
Centro 52
Novara 51
San Mateo 51
Brussels 47
Helsinki 46
Norwalk 44
Toronto 41
Rome 39
San Diego 39
Los Angeles 29
The Dalles 29
Falls Church 27
Kunming 26
Bologna 23
Jinan 23
Ottawa 23
Genoa 22
São Paulo 22
Xian 22
Silver Spring 21
Tokyo 21
Wuhan 21
Lappeenranta 20
Chengdu 19
Seoul 19
Verona 19
Mountain View 18
London 17
Munich 17
Washington 17
Nanchang 16
Paris 16
Scilla 16
Shenyang 16
Detroit 15
Garessio 15
San Francisco 15
Taipei 15
Zhengzhou 15
Falkenstein 14
Mexico City 14
Naples 14
Philadelphia 14
Upper Marlboro 14
Barcelona 13
Frankfurt am Main 13
Hebei 13
Perugia 13
Amsterdam 12
Berlin 12
Fuzhou 12
Lachine 12
Mumbai 12
Rio de Janeiro 12
Salvador 12
Belfast 11
Brookline 11
Changsha 11
Copenhagen 11
Totale 12.313
Salva come PNG Salva come JPEG
Nome #
Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia. 786
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications. 539
IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies 417
Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22 371
Subcellular characterization of NAD+ biosynthesis in metastatic melanoma by using organelle-specific biosensors 347
Mir-214 and mir-148b targeting inhibits dissemination of melanoma and breast cancer 326
The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. 243
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 237
Extracellular nicotinate phosphoribosyltransferasebinds Toll like receptor 4 and mediatesinflammation 222
Usage of IGHV4-39 with Stereotypic B Cell Receptor Is An Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome 199
Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma 199
The PD-1/PD-L1 axis contributes to T cell dysfunction in chronic lymphocytic leukemia. 192
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience 183
SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response 177
Anti-CD44 mAb for the treatment of B-cell chronic lymphocytic leukemia and other hematological malignancies: evaluation of patent WO2013063498. 172
NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation 170
Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts 168
Targeting metabolism and survival in chronic lymphocytic leukemia and richter syndrome cells by a novel NF-κB inhibitor 164
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma 161
NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation 160
Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia 155
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600 150
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal Cancer 146
The genetics of nodal marginal zone lymphoma 145
Analysis of the distribution of human CD38 and of its ligand CD31 in normal tissues. 144
Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma 141
SLAMF1/CD150 IS A SIGNALING RECEPTOR EXPRESSED BY A SUBSET OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS CHARACTERIZED BY A FAVORABLE PROGNOSIS 140
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death. 140
The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies 135
Immune response dysfunction in chronic lymphocytic leukemia: Dissecting molecular mechanisms and microenvironmental conditions 134
NAD+-metabolizing ecto-enzymes shape tumor-host interactions: the chronic lymphocytic leukemia model. 134
The heme biosynthesis-heme export axis is required for the modulation of the tricarboxylic acid cycle 133
THE PD-1/PD-L1 AXIS CONTRIBUTES TO T CELL DYSFUNCTION IN CHRONIC LYMPHOCYTIC LEUKEMIA 132
NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer 130
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma 127
Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment 125
CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells 125
USE OF CLINICAL EXOME SEQUENCING IN THE DIAGNOSTIC FLOW OF MONOGENIC KIDNEY DISEASES: THE PIEDMONT EXPERIENCE 125
ASSOCIATION BETWEEN RS12917707 SINGLE NUCLEOTIDE POLYMORPHISM AT THE UMOD PROMOTER REGION AND SERUM UROMODULIN LEVELS: IMPLICATIONS IN KIDNEY TRANSPLANTATION 118
NOVEL AND KNOWN MUTATIONS IDENTIFIED BY CLINICAL EXOME SEQUENCING FOR THE DIAGNOSIS OF POLYCYSTIC KIDNEY DISEASE 117
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient–derived xenograft mouse models 117
Nampt over-expression recapitulates the braf inhibitor resistant phenotype plasticity in melanoma 116
Slamf-1/CD150 Is a Signaling Receptor Expressed by a Subset of Chronic Lymphocytic Leukemia Patients Characterized by a Favorable Prognosis 115
Activation of functional oxytocin receptors stimulates cell proliferation in human trophoblast and choriocarcinoma cell lines 114
Abstract 5170: Metabolism and cancer: The CD38-NAMPT connection in chronic lymphocytic leukemia 114
The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation 114
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death 112
Adenosine Signaling Mediates Hypoxic Responses in the Chronic Lymphocytic Leukemia Microenvironment 112
BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to metabolic reprogramming and intrinsic resistant to BRAF inhibitors 110
Adult-onset CblC deficiency: a challenging diagnosis involving different adult clinical specialists 110
CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential 106
Abstract 2302: The extracellular form of NAMPT contributes to creating a proinflammatory environment in chronic lymphocytic leukemia 105
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia 104
CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome? 103
CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity 102
Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology 101
CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells 101
Abstract 2630: Nicotinamide activates the p53/miR-34a/SIRT1 tumor suppressor network leading to apoptosis of chronic lymphocytic leukemia cells 101
HLA and AB0 Polymorphisms May Influence SARS-CoV-2 Infection and COVID-19 Severity 101
CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival 100
CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus 100
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 99
B Cell Receptor signaling and genetic lesions in TP53 and CDKN2A/CDKN2B cooperate in Richter Transformation 99
Targeting the Adenosinergic Axis in the Eμ-TCL1 Chronic Lymphocytic Leukemia Mouse Model Offers Novel Therapeutic Opportunities 99
Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia 98
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 98
CD200 INCLUDED IN A 4-MARKER MODIFIED MATUTES SCORE PROVIDES OPTIMAL SENSITIVITYAND SPECIFICITY FOR THE DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA 95
Metabolic adaptation in colorectal cancer: heme export is required for the modulation of the tricarboxylic acid cycle. 95
The hidden life of NAD+-consuming ectoenzymes in the endocrine system. 94
A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine. 94
Mutations in NOTCH1 PEST Domain Orchestrate CCL19-Driven Homing of Chronic Lymphocytic Leukemia (CLL) Cells By Modulating the Gene DUSP22 93
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression 92
The PD-1/PD-L1 Axis Contributes to T Cell Dysfunction in Chronic Lymphocytic Leukemia 92
Extracellular Nicotinamide Phosphoribosyltransferase (NAMPT) Shapes the CLL Microenvironment Promoting Macrophage M2 Polarization Via a Non-Enzymatic Mechanism 92
CD38 expression and functional activities are up-regulated by IFN-gamma on human monocytes and monocytic cell lines. 91
All-trans retinoic acid inhibits the growth of breast cancer cells by up-regulating ICAM-1 expression. 91
CD38 at the junction between prognostic marker and therapeutic target 91
Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT) 91
The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy 90
The heme exporter FLVCR1a modulates the tricarboxylic acid cycle: a new target in colorectal cancer 90
Cationization of monoclonal antibodies: another step towards the 'magic bullet'? 89
Regulatory T-cell modulation by green tea in chronic lymphocytic leukemia. 89
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle. 89
HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study. 88
Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects. 88
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting. 87
Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia. 87
CD38 Workshop Report 86
Human CD38 and its ligand CD31 define a unique lamina propria T lymphocyte signaling pathway. 86
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia 86
The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells. 85
Metabolic adaptation in colorectal cancer: heme export is required for the down-modulation of the tricarboxylic acid cycle 85
HaTSPiL: A modular pipeline for high throughput sequencing data analysis 85
CD38 in chronic lymphocytic leukemia: from bench to bedside? 84
SLAMF1/CD150 Activates Autophagy in Chronic Lymphocytic Leukemia Cells, Modulating Chemotaxis and Responses to Therapy 84
HLA-G is a component of the CLL escape repertoire to generate immune suppression: impact of HLA-G 14 bp (rs66554220) polymorphism 84
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia. 84
Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia 83
Protective Role of the M-Sec-Tunneling Nanotube System in Podocytes 83
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 82
Totale 13.885
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.533
article - articoli 0
book - libri 0
conference - conferenze 11.448
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.981
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020271 0 0 0 0 0 0 0 0 0 0 179 92
2020/20212.532 172 195 151 107 281 145 271 173 354 236 164 283
2021/20222.668 126 111 139 192 156 162 176 121 106 250 606 523
2022/20233.613 399 343 78 387 280 870 267 207 401 110 168 103
2023/20241.848 224 309 113 70 147 224 71 153 30 107 143 257
2024/20254.200 68 293 194 529 1.075 379 192 271 703 374 122 0
Totale 21.132